Intermediate-Dose Cytarabine as Postinduction AML Therapy.

已完结 10 由 Carly Carly 发布于 2025/10/13 16:53:32

DOI:10.1056/EVIDoa2400326
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1056/EVIDoa2400326

New England Journal of Medicine (NEJM)

Abstract：Background: We conducted a randomized controlled trial to compare intermediate doses (IDAC) with high doses of cytarabine (HDAC) as postinduction therapy in patients 18 to 60 years of age wi

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Multi-functional porous materials with simultaneous high water flux, antifouling and antibacterial performances from ionicliquid grafted polyethersulfone. Polymer